A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

NCT06809400 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: LY4006896
DRUG: Placebo

Sponsor

Eli Lilly and Company